Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
America Great HealthAAGH EBITDA Margin % is 2,666.67% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 940 Biotechnology companies, America Great Health ranks better than 98.72% on this metric.
America Great Health (OTCPK:AAGH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
America Great Health EBITDA Margin % Related Terms
America Great Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for America Great Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AAGH vs ADTX, PKTX, BBLG: EBITDA Margin % Comparison
For the Biotechnology subindustry, America Great Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
America Great Health EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, America Great Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where America Great Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health (AAGH) has a EBITDA Margin % of 2,666.67% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on America Great Health and its competitors. According to the industry distribution chart, America Great Health ranks #12 out of 940 companies in the Biotechnology industry, placing it in the top 1.3%.
Is America Great Health's EBITDA Margin % too high?
America Great Health's current EBITDA Margin % is 2,666.67%. Based on the distribution chart, America Great Health ranks #12 out of 940 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does America Great Health's EBITDA Margin % compare to ADTX and PKTX?
According to the Biotechnology industry distribution chart, America Great Health ranks #12 out of 940 companies for EBITDA Margin %. This places America Great Health in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on America Great Health and its competitors. America Great Health's current EBITDA Margin % is 2,666.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current EBITDA Margin % of 2,666.67%. The current EBITDA Margin % is 2,666.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For America Great Health (AAGH), the current EBITDA Margin % is 2,666.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAGH has been successfully added to your 
